Skip to main content
SpringerLink
Log in

Clinical and Laboratory Manifestations of Paraneoplastic Rheumatic Syndromes

  • Chapter
  • First Online:
Gerontorheumatology

  • 717 Accesses

Abstract

Clinical manifestations of paraneoplastic rheumatic syndromes may coincide with a malignancy and follow or precede the diagnosis of cancer. According to Fam [1], the paraneoplastic syndromes should meet the following criteria:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fam AG. Paraneoplastic rheumatic syndromes. Clin Rheumatol. 2000;14(3):515–33.

    CAS  Google Scholar 

  2. Vavrdová V. Paraneoplastické revmatické syndromy. In: Rovenský J, et al., editors. Reumatológia v teórii a praxi VI. Martin: Osveta; 2004. p. 662–673. [In Slovak].

    Google Scholar 

  3. Praprotnik S, Tomšič M. Paraneoplastic arthritis. In: Shoenfeld Y, Gershwin ME, editors. Cancer and autoimmunity. Amsterdam: Elsevier Science; 2000. p. 133–40.

    Chapter  Google Scholar 

  4. Tomer Y, Shoenfeld Y. Autoantibodies, autoimmunity and cancer. In: Shoenfeld Y, Gershwin ME, editors. Cancer and autoimmunity. Amsterdam: Elsevier Science; 2000. p. 141–50.

    Chapter  Google Scholar 

  5. Solans-Laqué R, Perez-Bocanegra C, Salud-Salvia A, et al. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus. 2004;13:159–64.

    Article  PubMed  Google Scholar 

  6. Loche F, Schwarze HP, Durieu C, et al. A case of systemic lupus erythematosus associated with cancer of the lung: a paraneoplastic association? Br J Dermatol. 2000;143:210–1.

    Article  CAS  PubMed  Google Scholar 

  7. DiCataldo A, Villari L, Milone P, et al. Thymic carcinoma, systemic lupus erythematosus, and hypertrophic pulmonary osteoarthropathy in an II-year-old boy: a novel association. Pediatr Hematol Oncol. 2000;17:701–6.

    Article  CAS  Google Scholar 

  8. Cohen PR. Granuloma annulare, relapsing polychondritis, sarcoidosis, and systemic lupus erythematosus: conditions whose dermatologic manifestations may occur as hematologic malignancy-associated mucocutaneous paraneoplastic syndrome. Int J Dermatol. 2006;45:70–80.

    Article  PubMed  Google Scholar 

  9. Gomez-Puerta JA, Cervera R, Espinosa G. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum. 2006;35:322–32.

    Article  CAS  PubMed  Google Scholar 

  10. Miesbach W, Ascherson RA, Cervera R. The catastrophic antiphospholipid (Asherson’s) syndrome and malignancies. Autoimmun Rev. 2006;6:94–7.

    Article  CAS  PubMed  Google Scholar 

  11. Butler RC, Thompson JM, Keat ACS. Paraneoplastic rheumatic disorders: a review. J R Soc Med. 1987;80:168–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Miller SB, Donlan CJ, Roth SB. Hodgkin’s disease presenting as relapsing polychondritis. A previously undescribed association. Arthritis Rheum. 1974;17:598–602.

    Article  CAS  PubMed  Google Scholar 

  13. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma. 1977;24:483–9.

    Article  Google Scholar 

  14. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukaemia. Leuk Lymphoma. 2002;43:2083–92.

    Article  PubMed  Google Scholar 

  15. Awadh B, Abdou NI. Rising erythrocyte sedimentation rate in a patient with treated polymyalgia rheumatica: colon cancer as an accidental association versus paraneoplastic syndrome. J Clin Rheumatol. 2006;12(2):102.

    Article  PubMed  Google Scholar 

  16. Miklošková E, Kmečová Z. Polymyalgia rheumatica a nádor hrubého čreva – kazuistika. VIII.Siťajov predvianočný reumatologický seminár 3.–4. 12. 2004 v Piešťanoch. [In Slovak].

    Google Scholar 

  17. Keith MP, Gilliland WR. Polymyalgia rheumatica and breast cancer. J Clin Rheumatol. 2006;12:199–200.

    Article  PubMed  Google Scholar 

  18. Kane I, Menon S. Carcinoma of the prostate presenting as polymyalgia rheumatica. Br Soc Rheumatol. 2003;42:385–7.

    Article  CAS  Google Scholar 

  19. Megalakaki A, Mitsouli C, Pontikoglou C. Chronic idiopathic neutropenia preceding polymyalgia rheumatica and acute myeloid leukemia. Ann Hematol. 2004;83:791–2.

    Article  CAS  PubMed  Google Scholar 

  20. Liozon E, Loustaud V, Fauchais AL, et al. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol. 2006;33:1606–14.

    PubMed  Google Scholar 

  21. Castro M, Conn DL, Su WPD, et al. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol. 1991;18:721–7.

    CAS  PubMed  Google Scholar 

  22. Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol. 1995;91:403–8.

    Article  CAS  PubMed  Google Scholar 

  23. Giannouli S, Voulgarelis M, Zintzaras E, et al. Autoimmune phenomena in myelodysplastic syndromes: a 4-year prospective study. Rheumatology (Oxford). 2004;43:626–32.

    Article  CAS  Google Scholar 

  24. Espinosa G, Font J, Munoz-Rodriguez FJ, et al. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol. 2000;21:309–13.

    Article  Google Scholar 

  25. Kohli M, Bennett RM. An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol. 1994;21:1357–9.

    CAS  PubMed  Google Scholar 

  26. Billstrom R, Johansson H, Johansson B, et al. Immunomediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic features. Eur J Haematol. 1995;55:42–8.

    Article  CAS  PubMed  Google Scholar 

  27. Steuer M, Fritsche G, Tzankov A, et al. Large vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol. 2004;73:128–33.

    Article  Google Scholar 

  28. Lopez FF, Vaidyan PB, Mega AE, et al. Aortitis as a manifestation of myelodysplastic syndrome. Postgrad Med J. 2001;77:116–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kovalančík M. Multicentrická retikulohistiocytóza. In: Rovenský J, et al., editors. Reumatologia v teórii a praxi V. Martin: Osvetal; 1998. p. 525–532. [In Slovak].

    Google Scholar 

  30. Luz FB, Gaspar TAP, Kalil-Gaspas N, et al. Multicentre reticulohistiocytosis. J Eur Acad Dermatol Venereol. 2001;15:524–31.

    Article  CAS  PubMed  Google Scholar 

  31. Barrow MV, Holubar K. Multicentre reticulohistiocytosis. Medicine. 1969;48:287–305.

    Article  CAS  PubMed  Google Scholar 

  32. Caterrall M, White J. Multicentre reticulohistiocytosis and malignant disease. Br J Dermatol. 1978;98:221–4.

    Article  Google Scholar 

  33. Nunnick JC, Krusinski PA, Yates JW. Multicentre reticulohistiocytosis and cancer: a case report and review of the literature. Med Pediatr Oncol. 1985;13:273–9.

    Article  Google Scholar 

  34. Chub-Hsiung C, Chih-Hsueh C, Horng-An C, et al. Multicentric reticulohistiocytosis presenting with destructive polyarthritis, laryngopharyngeal dysfunction, and a huge reticulohistiocytoma. J Clin Rheumatol. 2006;12:252–4.

    Article  Google Scholar 

  35. Schapira D, Izhak OB, Nachtigal A, et al. Tumor-induced osteomalacia. Semin Arthritis Rheum. 1995;1:35–46.

    Article  Google Scholar 

  36. Bayer M, Kutílek Š, et al. Metabolická onemocnění skeletu u dětí. Prague: Grada Publishing; 2002. [In Czech].

    Google Scholar 

  37. McCarty DJ, O’Duffy JD, Pearson L, et al. Remitting seronegative symmetrical synovitis with pitting edema. J Am Med Assoc. 1985;254:2763–7.

    Article  CAS  Google Scholar 

  38. Molina R, Martinez T, Roman J, et al. Non-Hodgkins lymphoma: initial manifestation. Ann Rheum Dis. 1993;52:85–6.

    Article  Google Scholar 

  39. Olive A, del Blanco J, Pons M, et al. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. J Rheumatol. 1997;24:333–6.

    CAS  PubMed  Google Scholar 

  40. Olivo D, Mattace R. Concurrence of benign edematous polysynovitis in the elderly (RS3PE syndrome) and endometrial adenocarcinoma. Scand J Rheumatol. 1997;27:66–8.

    Google Scholar 

  41. Tada Y, Sato H, Yoshizawa S, et al. Remitting seronegative symmetrical synovitis with pitting edema associated with gastric carcinoma. J Rheumatol. 1997;24:974–5.

    CAS  PubMed  Google Scholar 

  42. Sibilia J, Friess S, Schaeverbeke T, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol. 1999;26:115–20.

    CAS  PubMed  Google Scholar 

  43. Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol. 1999;17:741–4.

    CAS  PubMed  Google Scholar 

  44. Russell E. Remitting seronegative symmetrical synovitis with pitting edema syndrome: following for neoplasia. J Rheumatol. 2005;32:1760–1.

    PubMed  Google Scholar 

  45. Fietta P, Manganelli P. Remitting seronegative symmetrical synovitis with pitting edema syndrome: follow-up for neoplasia. J Rheumatol. 2006;33:2365–6. To the editor.

    PubMed  Google Scholar 

  46. Abu-Shakra M, Buskila D, Conrad K, et al. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis. 2001;60:433–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Shiel WC, Jason M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol. 1989;16:782–5.

    PubMed  Google Scholar 

  48. Rovenský J, Tuchyňová A. Polymyalgia rheumatica, temporal arteritis and occurrence of malignant tumours. In: Rovenský J et al., editors. Polymyalgia rheumatica and giant cell arteritis. Bratislava: SAP; 2007. p. 15–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský

  2. National Institute of Oncology, Bratislava, Slovakia

    Ľubica Švancárová

Authors
  1. Jozef Rovenský
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ľubica Švancárová
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jozef Rovenský .

Editor information

Editors and Affiliations

  1. National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rovenský, J., Švancárová, Ľ. (2017). Clinical and Laboratory Manifestations of Paraneoplastic Rheumatic Syndromes. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31169-2_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31167-8

  • Online ISBN: 978-3-319-31169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation